Studies have demonstrated that XIST facilitates PD progression by upregulating Sp1 and LRRK2 expression, this upregulation promotes apoptosis while suppressing cell proliferation, ultimately exacerbating the neurodegenerative process. The gene discussed is LRRK2; the disease is Parkinson disease.